Organizing Pneumonia Related to Common Variable Immunodeficiency
Wislez M.a,e · Sibony M.b,e · Naccache J.-M.a · Liote H.a · Carette M.-F.c · Oksenhendler E.d · Cadranel J.a,e
Case Reportand Literature Review
Services deaPneumologie et de Réanimation Respiratoire, bd’Anatomie-Pathologique, et de cRadiologie, AP-HP, Hôpital Tenon, dService d’Immuno-Hématologie, AP-HP, Hôpital Saint-Louis, eLaboratoire de Biologie Cellulaire et d’Immunopathologie Pulmonaire, UPRES EA 1531, Université Paris VI, Paris, France
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
A 68-year-old woman suffering from common variable immunodeficiency (CVI) developed a typical picture of organizing pneumonia. Causative factors other than CVI were eliminated. Several antibiotic regimens failed to improve the patient’s condition, while the clinical manifestations rapidly disappeared under steroid therapy, with complete radiological recovery, but relapsed after steroid withdrawal. Finally, organizing pneumonia was definitely demonstrated by pathological findings obtained by open lung biopsy. Interestingly, pathological examination exhibited two other well-known CVI-associated lesions, i.e. benign lymphoid hyperplasia and noncaseating granuloma. In view of reports in the literature, we speculate that these different histological patterns could have resulted in a spectrum of symptomatic CVI-associated pulmonary disorders that improved under steroid therapy.
© 2000 S. Karger AG, Basel
- Sneller MC, Strober W, Eisenstein E, Jaffe JS, Cunningham-Rundles C: NIH conference. New insights into common variable immunodeficiency. Ann Intern Med 1993;118:720–730.
- Hermaszewski RA, Webster AD: Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. Q J Med 1993;86:31–42.
- Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES: Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 1992;16:1170–1182.
- Fishback N, Koss M: Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med 1996;2:429–433.
- Mechanic LJ, Dikman S, Cunningham-Rundles C: Granulomatous disease in common variable innunodeficiency. Ann Intern Med 1997;127:613–617.
- Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ, Lederman HM, Bykowsky MJ, Greene JM, Winkelstein JA: Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 1996;75:251–261.
- Kaufman J, Komorowski R: Bronchiolitis obliterans organizing pneumonia in common variable immunodeficiency syndrome. Chest 1991;100:552–553.
Soto Campos JG, Cano Gomez S, Capote Gil F, Epler GR: Bronchiolitis obliterans organizing pneumonia and common variable immunodeficiency (in Spanish). Arch Bronconeumol 1997;33:548.
- Nagai S, Izumi T: Bronchiolitis obliterans with organizing pneumonia. Curr Opin Pulm Med 1996;2:419–423.
- Hermans PE, Diaz-Buxo JA, Stobo JD: Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med 1976;61:221–237.
- Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA: Lymphoid interstitial pneumonia: Clinicopathological and immunopathological findings in 18 cases. Pathology 1987;19:178–185.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.